Fact CheckerSign in

NCT06128265Completed

Sleep Extension or Regularity to Reduce Diabetes Risk

Source: ClinicalTrials.gov · Last updated 2 Jul 2026

Brief summary (registry, in English)

The goal of this study is to identify an intervention that improves sleep health and consequently metabolic health by examining whether sleep extension or enforced regularity in short sleepers will have beneficial effects on diabetes and obesity risk.

Status (registry)
Completed
Study type
Interventional
Enrollment
18 (actual)
First submitted
7 Nov 2023
Start date
3 Jan 2024
Primary completion date
31 Dec 2024
Lead sponsor
University of Chicago
Diseases
Obesity
NCT number
NCT06128265

What you commit to

  • Study type: Interventional
  • Participants enrolled: 18
  • From 3 Jan 2024 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Drug and nicotine use
  • Subjects who have undergone bariatric surgery,
  • Subjects who worked night shifts, or crossed any time zones in the month prior to the study.

Other

  • Habitual alcohol use of more than 2 drinks per day
  • Caffeine intake of more than 500 mg per day
  • Subjects who participated in medically managed weight loss program within the past year
  • Subjects who have dietary restrictions,
  • Sleep-disordered breathing (apnea-hypopnea index\>15 events/hour) from an overnight at home sleep test (NOX)
  • Peri- and post-menopausal women will not be included.

Who the study is looking for

  • African American or Black men and women
  • Age 21-50 years old
  • Overweight (BMI greater than or equal 25 kg/m2 and less than 35 kg/m2)
  • Self-reported short sleep (less than 7hrs/night, sleep between 22:00-08:00, and who indicate they could sleep more if they had the opportunity)
  • No previously diagnosed sleep disorders (including obstructive sleep apnea (OSA))
  • No existing diagnosis of diabetes
  • No history of endocrine dysfunction
  • No history of psychiatric, cardiovascular, or eating disorders, not having a gastro-intestinal disease that requires dietary adjustment,
  • Currently taking no medications (excluding statins and birth control)

Age in the registry: 21 years to 50 years · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
University of Chicago
Coordinator of this site? Confirm its status
ChicagoUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.